MORGAN STANLEY PLC/PUT/PFIZER INC/40/0.1/20.06.25 Stock

Warrant

DE000MB6JBL5

Market Closed - Börse Stuttgart 14:30:26 2024-07-03 EDT
1.17 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/PUT/PFIZER INC/40/0.1/20.06.25
Current month+1.74%
1 month+15.84%
Date Price Change
24-07-03 1.17 0.00%
24-07-02 1.17 +2.63%
24-07-01 1.14 -0.87%
24-06-28 1.15 -2.54%
24-06-27 1.18 -3.28%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 02:30 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB6JBL
ISINDE000MB6JBL5
Date issued 2023-05-24
Strike 40 $
Maturity 2025-06-20 (352 Days)
Parity 10 : 1
Emission price 0.58
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.42
Lowest since issue 0.41
Spread 0.01
Spread %0.85%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus